EVELYN DUFFY: Open Payments
NPI 1689615700 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 15 payments from 9 companies in 2025. Trend: 2023 $494 · 2024 $812 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $55 |
| Merck Sharp & Dohme LLC | 3 | $53 |
| Astellas Pharma US Inc | 2 | $43 |
| PFIZER INC. | 2 | $42 |
| Gilead Sciences, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $20 |
| Abbott Laboratories | 1 | $20 |
| Amgen Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: Veozah, ELIQUIS, GARDASIL 9, MOUNJARO, FREESTYLE LIBRE 3, Ozempic, REPATHA, GVOKE HYPOPEN.
Industry payments across OH — which companies pay providers there.
